Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) - Related Studies

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

This study has been completed.

Study NCT00077792. Last updated on June 18, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Myocardial Infarction
		Acute ST-Segment Elevation

2	Additional conditions recognized in this trial
		Infarction

3	More general conditions related to this trial
		Cardiovascular Diseases
		Heart Diseases
		Ischemia
		Myocardial Ischemia
		Necrosis
		Pathologic Processes
		Vascular Diseases

4	Interventions listed in this trial
		Enoxaparin sodium (XRP4563)

5	Additional drug interventions recognized in this trial
		Enoxaparin

6	More general drug interventions related to this trial
		Anticoagulants
		Cardiovascular Agents
		Fibrin Modulating Agents
		Fibrinolytic Agents
		Hematologic Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Sanofi-Aventis